Stock data
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. (SER) reported revenue of US$0.13M and net income of -US$19.18M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.13M | — | -US$24.02M | -US$19.18M | — |
| 2024 | US$0.06M | — | -US$17.05M | -US$11.14M | — |
| 2023 | US$3.15M | US$0.10M | -US$3.13M | US$5.27M | — |
| 2022 | US$0.03M | US$0.02M | -US$6.97M | -US$10.46M | — |
| 2021 | US$0.14M | US$0.12M | -US$7.93M | -US$8.68M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$6.36M | — |
| 2026-03-31 | — | -US$6.90M | — |
| 2025-12-31 | US$0.00M | -US$3.34M | — |
| 2025-09-30 | US$0.00M | -US$4.58M | — |
| 2025-06-30 | US$0.13M | -US$6.45M | — |
| 2025-03-31 | US$0.00M | -US$4.81M | — |
| 2024-12-31 | -US$0.01M | -US$2.74M | — |
| 2024-09-30 | US$0.01M | US$1.41M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.